Torrent Pharmaceuticals Limited (TORNTPHARM.BO)
INR 3244.5
(0.37%)
INR 3244.5
(0.37%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 16.56 Billion INR | 33.02% |
| 2022 | 12.45 Billion INR | 60.22% |
| 2021 | 7.77 Billion INR | -37.92% |
| 2020 | 12.51 Billion INR | 22.17% |
| 2019 | 10.24 Billion INR | 134.88% |
| 2018 | 4.36 Billion INR | -35.66% |
| 2017 | 6.78 Billion INR | -27.36% |
| 2016 | 9.33 Billion INR | -46.14% |
| 2015 | 17.33 Billion INR | 130.81% |
| 2014 | 7.5 Billion INR | 13.11% |
| 2013 | 6.63 Billion INR | 53.41% |
| 2012 | 4.32 Billion INR | 52.36% |
| 2011 | 2.84 Billion INR | 5.13% |
| 2010 | 2.7 Billion INR | 16.86% |
| 2009 | 2.31 Billion INR | 25.4% |
| 2008 | 1.84 Billion INR | 36.9% |
| 2007 | 1.34 Billion INR | 44.02% |
| 2006 | 935.13 Million INR | 83.85% |
| 2005 | 508.62 Million INR | 4.31% |
| 2004 | 487.61 Million INR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 4.57 Billion INR | 1.7% |
| 2024 Q2 | 4.53 Billion INR | -0.88% |
| 2023 Q2 | 3.86 Billion INR | 2.12% |
| 2023 Q3 | 4.43 Billion INR | 14.77% |
| 2023 Q1 | 3.78 Billion INR | 27.6% |
| 2023 FY | 16.56 Billion INR | 33.02% |
| 2023 Q4 | 4.49 Billion INR | 1.44% |
| 2022 Q4 | 2.96 Billion INR | 1.45% |
| 2022 Q3 | 2.92 Billion INR | -6.41% |
| 2022 FY | 12.45 Billion INR | 60.22% |
| 2022 Q1 | 3.54 Billion INR | 400.46% |
| 2022 Q2 | 3.12 Billion INR | -11.86% |
| 2021 FY | 7.77 Billion INR | -37.92% |
| 2021 Q2 | 3.16 Billion INR | -4.24% |
| 2021 Q1 | 3.3 Billion INR | 1.89% |
| 2021 Q3 | 2.49 Billion INR | -21.2% |
| 2021 Q4 | -1.17 Billion INR | -147.32% |
| 2020 Q3 | 2.97 Billion INR | -4.19% |
| 2020 Q4 | 3.23 Billion INR | 9.05% |
| 2020 FY | 12.51 Billion INR | 22.17% |
| 2020 Q2 | 3.1 Billion INR | -3.43% |
| 2020 Q1 | 3.21 Billion INR | 2.32% |
| 2019 Q2 | 2.44 Billion INR | 12.96% |
| 2019 FY | 10.24 Billion INR | 134.88% |
| 2019 Q3 | 2.51 Billion INR | 2.87% |
| 2019 Q1 | 2.16 Billion INR | 242.37% |
| 2019 Q4 | 3.13 Billion INR | 24.99% |
| 2018 Q3 | 2.46 Billion INR | 37.43% |
| 2018 Q2 | 1.79 Billion INR | 9.82% |
| 2018 FY | 4.36 Billion INR | -35.66% |
| 2018 Q4 | -1.51 Billion INR | -161.67% |
| 2018 Q1 | 1.63 Billion INR | -28.51% |
| 2017 Q4 | 2.28 Billion INR | 293.1% |
| 2017 FY | 6.78 Billion INR | -27.36% |
| 2017 Q3 | 580 Million INR | -71.57% |
| 2017 Q2 | 2.04 Billion INR | 8.51% |
| 2017 Q1 | 1.88 Billion INR | -8.74% |
| 2016 Q1 | 2.92 Billion INR | 2.82% |
| 2016 FY | 9.33 Billion INR | -46.14% |
| 2016 Q4 | 2.06 Billion INR | -10.04% |
| 2016 Q3 | 2.29 Billion INR | 10.63% |
| 2016 Q2 | 2.07 Billion INR | -29.11% |
| 2015 Q1 | 6.5 Billion INR | 400.23% |
| 2015 Q3 | 2.9 Billion INR | -43.03% |
| 2015 Q4 | 2.84 Billion INR | -2.07% |
| 2015 FY | 17.33 Billion INR | 130.81% |
| 2015 Q2 | 5.09 Billion INR | -21.69% |
| 2014 Q4 | 1.29 Billion INR | -22.19% |
| 2014 Q2 | 1.98 Billion INR | -22.66% |
| 2014 FY | 7.5 Billion INR | 13.11% |
| 2014 Q1 | 2.56 Billion INR | 4.97% |
| 2014 Q3 | 1.67 Billion INR | -15.66% |
| 2013 Q2 | 1.13 Billion INR | -24.16% |
| 2013 Q4 | 2.43 Billion INR | 54.35% |
| 2013 FY | 6.63 Billion INR | 53.41% |
| 2013 Q3 | 1.58 Billion INR | 39.82% |
| 2013 Q1 | 1.49 Billion INR | 33.84% |
| 2012 Q3 | 1.12 Billion INR | 4.67% |
| 2012 Q2 | 1.07 Billion INR | 4.9% |
| 2012 FY | 4.32 Billion INR | 52.36% |
| 2012 Q1 | 1.02 Billion INR | 6265.0% |
| 2012 Q4 | 1.11 Billion INR | -0.6% |
| 2011 Q3 | 831.8 Million INR | 0.0% |
| 2011 FY | 2.84 Billion INR | 5.13% |
| 2011 Q4 | -16.54 Million INR | -101.99% |
| 2010 FY | 2.7 Billion INR | 16.86% |
| 2009 FY | 2.31 Billion INR | 25.4% |
| 2008 FY | 1.84 Billion INR | 36.9% |
| 2007 FY | 1.34 Billion INR | 44.02% |
| 2006 FY | 935.13 Million INR | 83.85% |
| 2005 FY | 508.62 Million INR | 4.31% |
| 2004 FY | 487.61 Million INR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 6.15 Billion INR | -168.971% |
| Aurobindo Pharma Limited | 31.72 Billion INR | 47.797% |
| Glenmark Life Sciences Limited | 4.7 Billion INR | -251.757% |
| Granules India Limited | 4.05 Billion INR | -308.67% |
| Indoco Remedies Limited | 984.6 Million INR | -1582.286% |
| Achyut Healthcare Limited | 5.73 Million INR | -288870.691% |
| Ajanta Pharma Limited | 8.16 Billion INR | -102.945% |
| Alkem Laboratories Limited | 17.95 Billion INR | 7.762% |
| Alpa Laboratories Limited | 167.76 Million INR | -9773.216% |
| Brooks Laboratories Limited | -195.91 Million INR | 8554.412% |
| AstraZeneca Pharma India Limited | 1.61 Billion INR | -925.559% |
| Bajaj HealthCare Limited | -837.93 Million INR | 2076.75% |
| Bliss GVS Pharma Limited | 754.54 Million INR | -2095.215% |
| Dr. Reddy's Laboratories Limited | 55.68 Billion INR | 70.254% |
| Eris Lifesciences Limited | 3.91 Billion INR | -322.564% |
| FDC Limited | 3.05 Billion INR | -442.678% |
| Glenmark Pharmaceuticals Limited | -15.01 Billion INR | 210.303% |
| Gufic Biosciences Limited | 861.35 Million INR | -1822.991% |
| Ind-Swift Laboratories Limited | 4.2 Billion INR | -293.475% |
| Ipca Laboratories Limited | 5.47 Billion INR | -202.618% |
| Jagsonpal Pharmaceuticals Limited | 224.63 Million INR | -7273.815% |
| Krebs Biochemicals & Industries Limited | -197.28 Million INR | 8495.917% |
| Lasa Supergenerics Limited | -217.3 Million INR | 7722.339% |
| Laurus Labs Limited | 1.6 Billion INR | -931.691% |
| Lupin Limited | 19.14 Billion INR | 13.481% |
| Mankind Pharma Limited | 19.12 Billion INR | 13.41% |
| Medicamen Biotech Limited | 109.31 Million INR | -15053.051% |
| Medico Remedies Limited | 82.9 Million INR | -19878.289% |
| Megasoft Limited | -127.46 Million INR | 13094.681% |
| NATCO Pharma Limited | 13.88 Billion INR | -19.31% |
| Piramal Pharma Limited | 178.2 Million INR | -9195.062% |
| RPG Life Sciences Limited | 876.6 Million INR | -1789.551% |
| Sigachi Industries Limited | 571.8 Million INR | -2796.772% |
| Sun Pharmaceutical Industries Limited | 95.76 Billion INR | 82.703% |
| Suven Pharmaceuticals Limited | 3 Billion INR | -451.611% |
| Syncom Formulations (India) Limited | 253.14 Million INR | -6443.284% |
| Unichem Laboratories Limited | -704.74 Million INR | 2450.332% |
| Wanbury Limited | 559.56 Million INR | -2860.131% |
| Windlas Biotech Limited | 581.87 Million INR | -2746.65% |
| ZIM Laboratories Limited | 172.46 Million INR | -9504.207% |
| Zydus Lifesciences Limited | 38.59 Billion INR | 57.083% |
| Sun Pharma Advanced Research Company Limited | -3.87 Billion INR | 527.769% |
| Divi's Laboratories Limited | 16 Billion INR | -3.524% |
| Hester Biosciences Limited | 188.89 Million INR | -8669.019% |
| Procter & Gamble Health Limited | 2 Billion INR | -724.152% |
| Amrutanjan Health Care Limited | 449.72 Million INR | -3583.087% |
| Bal Pharma Limited | 73.92 Million INR | -22307.132% |
| Strides Pharma Science Limited | -706.14 Million INR | 2445.682% |
| Venus Remedies Limited | 284.9 Million INR | -5713.736% |
| Aarti Pharmalabs Limited | 2.16 Billion INR | -663.654% |
| Nectar Lifesciences Limited | 49.95 Million INR | -33060.761% |
| Shilpa Medicare Limited | 318.74 Million INR | -5096.617% |
| Aarti Drugs Limited | 1.71 Billion INR | -866.28% |
| IOL Chemicals and Pharmaceuticals Limited | 1.34 Billion INR | -1132.151% |
| Suven Life Sciences Limited | -1.05 Billion INR | 1676.359% |
| Ind-Swift Limited | 142.31 Million INR | -11538.993% |
| Valiant Laboratories Limited | 3.19 Million INR | -518166.583% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.52 Billion INR | -199.728% |
| Solara Active Pharma Sciences Limited | -5.67 Billion INR | 391.93% |
| Themis Medicare Limited | 435.23 Million INR | -3705.688% |
| Hikal Limited | 696.02 Million INR | -2279.788% |
| Sequent Scientific Limited | -358.69 Million INR | 4717.859% |
| Novartis India Limited | 851.9 Million INR | -1844.336% |
| Wockhardt Limited | -4.63 Billion INR | 457.749% |
| Jubilant Pharmova Limited | 771 Million INR | -2048.353% |
| Biofil Chemicals and Pharmaceuticals Limited | 7.09 Million INR | -233456.12% |
| Neuland Laboratories Limited | 3 Billion INR | -451.981% |
| Morepen Laboratories Limited | 961.59 Million INR | -1622.527% |
| Kilitch Drugs (India) Limited | 146.01 Million INR | -11243.981% |
| Mangalam Drugs & Organics Limited | -90.71 Million INR | 18358.761% |